ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
83.76
+1.49 (1.81%)
Jun 12, 2026, 11:17 AM EDT - Market open
BIB Holdings Information
BIB is an equity ETF with a total of 262 individual holdings.
Total Holdings
262
Top 10 Percentage
152.30%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
69.83M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 29.92% |
| 2 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 29.39% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 26.11% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 22.41% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 21.34% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 5.37% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 4.91% |
| 8 | AMGN | Amgen Inc. | 4.88% |
| 9 | GILD | Gilead Sciences, Inc. | 4.57% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.40% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.10% |
| 12 | RVMD | Revolution Medicines, Inc. | 1.56% |
| 13 | BIIB | Biogen Inc. | 1.55% |
| 14 | ILMN | Illumina, Inc. | 1.35% |
| 15 | ARGX | argenx SE | 1.33% |
| 16 | UTHR | United Therapeutics Corporation | 1.30% |
| 17 | RPRX | Royalty Pharma plc | 1.27% |
| 18 | INCY | Incyte Corporation | 1.14% |
| 19 | ROIV | Roivant Sciences Ltd. | 1.11% |
| 20 | INSM | Insmed Incorporated | 1.08% |
| 21 | MRNA | Moderna, Inc. | 0.99% |
| 22 | VTRS | Viatris Inc. | 0.99% |
| 23 | GH | Guardant Health, Inc. | 0.93% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 0.88% |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 0.77% |
As of Jun 10, 2026